119 related articles for article (PubMed ID: 12113806)
1. Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.
Gao LJ; Waelbroeck M; Hofman S; Van Haver D; Milanesio M; Viterbo D; De Clercq PJ
Bioorg Med Chem Lett; 2002 Aug; 12(15):1909-12. PubMed ID: 12113806
[TBL] [Abstract][Full Text] [Related]
2. Himbacine analogs as muscarinic receptor antagonists--effects of tether and heterocyclic variations.
Chackalamannil S; Doller D; McQuade R; Ruperto V
Bioorg Med Chem Lett; 2004 Aug; 14(15):3967-70. PubMed ID: 15225708
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and muscarinic M2 subtype antagonistic activity of unnatural ent-himbacine and an enantiomeric pair of (2'S,6'R)-diepihimbacine.
Takadoi M; Terashima S
Bioorg Med Chem Lett; 2002 Oct; 12(20):2871-3. PubMed ID: 12270166
[TBL] [Abstract][Full Text] [Related]
4. Synthetic studies on himbacine, a potent antagonist of the muscarinic M2 subtype receptor. Part 2: synthesis and muscarinic M2 subtype antagonistic activity of the novel himbacine congeners modified at the C-3 position of lactone moiety.
Takadoi M; Yamaguchi K; Terashima S
Bioorg Med Chem; 2003 Apr; 11(7):1169-86. PubMed ID: 12628644
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and muscarinic M(2) subtype antagonistic activity of enantiomeric pairs of 3-demethylhimbacine (3-norhimbacine) and its C(4)-epimer.
Takadoi M; Yamaguchi K; Terashima S
Bioorg Med Chem Lett; 2002 Nov; 12(22):3271-3. PubMed ID: 12392730
[TBL] [Abstract][Full Text] [Related]
6. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
Miller JH; Aagaard PJ; Gibson VA; McKinney M
J Pharmacol Exp Ther; 1992 Nov; 263(2):663-7. PubMed ID: 1331410
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists.
Doller D; Chackalamannil S; Czarniecki M; McQuade R; Ruperto V
Bioorg Med Chem Lett; 1999 Mar; 9(6):901-6. PubMed ID: 10206558
[TBL] [Abstract][Full Text] [Related]
8. A novel short convergent entry into himbacine derivatives.
Van Cauwenberge G; Gao LJ; Van Haver D; Milanesio M; Viterbo D; De Clercq PJ
Org Lett; 2002 May; 4(9):1579-82. PubMed ID: 11975633
[TBL] [Abstract][Full Text] [Related]
9. Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor.
Kozlowski JA; Lowe DB; Guzik HS; Zhou G; Ruperto VB; Duffy RA; McQuade R; Crosby G; Taylor LA; Billard W; Binch H; Lachowicz JE
Bioorg Med Chem Lett; 2000 Oct; 10(20):2255-7. PubMed ID: 11055332
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
[TBL] [Abstract][Full Text] [Related]
11. Himbacine recognizes a high affinity subtype of M2 muscarinic cholinergic receptors in the rat cerebral cortex.
Wang JX; Roeske WR; Wang W; Yamamura HI
Brain Res; 1988 Apr; 446(1):155-8. PubMed ID: 3370478
[TBL] [Abstract][Full Text] [Related]
12. The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptors in vitro.
Eglen RM; Montgomery WW; Dainty IA; Dubuque LK; Whiting RL
Br J Pharmacol; 1988 Dec; 95(4):1031-8. PubMed ID: 3219478
[TBL] [Abstract][Full Text] [Related]
13. Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors.
Purkerson SL; Potter LT
J Pharmacol Exp Ther; 1998 Feb; 284(2):707-13. PubMed ID: 9454818
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of myopia development in chicks using himbacine: a role for M(4) receptors?
Cottriall CL; Truong HT; McBrien NA
Neuroreport; 2001 Aug; 12(11):2453-6. PubMed ID: 11496128
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.
Scapecchi S; Nesi M; Matucci R; Bellucci C; Buccioni M; Dei S; Guandalini L; Manetti D; Martelli C; Martini E; Marucci G; Orlandi F; Romanelli MN; Teodori E; Cirilli R
J Med Chem; 2010 Jan; 53(1):201-7. PubMed ID: 19928767
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.
Böhme TM; Augelli-Szafran CE; Hallak H; Pugsley T; Serpa K; Schwarz RD
J Med Chem; 2002 Jul; 45(14):3094-102. PubMed ID: 12086495
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.
Wess J; Gdula D; Brann MR
Mol Pharmacol; 1992 Feb; 41(2):369-74. PubMed ID: 1538713
[TBL] [Abstract][Full Text] [Related]
18. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
[TBL] [Abstract][Full Text] [Related]
19. Himbacine discriminates between putative muscarinic M1 receptor-mediated responses.
Sagrada A; Duranti P; Giudici L; Schiavone A
Life Sci; 1994; 54(17):PL305-10. PubMed ID: 7513038
[TBL] [Abstract][Full Text] [Related]
20. Interaction of himbacine with carbachol at muscarinic receptors of heart and smooth muscle.
Gilani SA; Cobbin LB
Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):46-53. PubMed ID: 3446043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
